相关实验视频

Updated: Jun 7, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

在阿尔茨海默病中研究神经免疫相互作用的方法

Chih-Chung 'Jerry' Lin¹, Yuyao Tian¹, Rudolph E Tanzi¹

¹Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.

Trends in immunology

|November 13, 2024

概括

周围免疫细胞显著影响阿尔茨海默病 (AD) 病理学. 研究使用先进的模型来了解免疫细胞的作用,为新的基于免疫的AD疗法铺平了道路.

科学领域:

神经免疫学神经免疫学
阿尔茨海默氏症疾病的发病因子

背景情况:

外围免疫细胞极大地影响阿尔茨海默病 (AD) 的进展,影响粉样蛋白和蛋白病理,质细胞激活和认知能力下降.
了解这些细胞的精确作用对于开发有效的AD治疗至关重要.

研究的目的:

审查当前和新兴的策略,以调查边缘免疫细胞参与阿尔茨海默病.
突出现有模型的优点和局限性,并倡导更多与人类相关的方法.

主要方法:

对各种动物和细胞模型的检查,包括在小鼠模型中进行抗体介导的枯竭,基因切除和骨髓嵌合体.
对模仿人类大脑组织和神经免疫相互作用的新兴多细胞模型的分析.

主要成果:

鼠标模型已经阐明了AD中T细胞,B细胞和先天性免疫细胞的疾病修饰功能.
关于模型特异性,非目标效应以及人与老鼠免疫系统差异的挑战仍然存在.
新的多细胞模型正在为人类神经免疫相互作用提供新的见解.

结论:

在AD中研究外围免疫细胞的精细化方法至关重要.
增强的理解可以加速开发针对阿尔茨海默病的新型免疫相关治疗干预措施.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.模型模型模型模型周边免疫细胞是什么?

更多相关视频

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...